CAXTON ASSOCIATES LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q1 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAXTON ASSOCIATES LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2021$346,000
+69.6%
6,528
+218.9%
0.04%
-5.4%
Q1 2020$204,000
-31.3%
2,047
-17.0%
0.04%
+2.8%
Q2 2019$297,000
-4.5%
2,467
-9.0%
0.04%
+71.4%
Q3 2018$311,0002,7100.02%
Other shareholders
HAEMONETICS CORP shareholders Q1 2020
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders